Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-019766

Options or other derivatives

  • Chief Fin. & Admin Officer acquired 81,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
MELLETT PAUL J Chief Fin. & Admin Officer 2024-11-27 Grant or award · Stock Option (right to buy) +81,000 81,000 D
Loading xslF345X05/form4.xml…